09:24 AM EST, 02/27/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) reported Q4 earnings Thursday of $0.01 per diluted share, swinging from a loss of $0.19 a year earlier.

Analysts polled by FactSet expected a loss of $0.02.

Revenue for the quarter ended Dec. 31 was $59.9 million, up from $45.1 million a year earlier.

Analysts surveyed by FactSet expected $60.1 million.

The company said it expects 2025 revenue of $250 million to $260 million.

Analysts polled by FactSet expect $274.4 million.